These proteins include tau (MAPT) and alpha-synuclein (SYUA), which are important biomarkers for Alzheimer’s disease [27], [28] and Parkinson’s disease [29], respectively (Figure 3F). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.